Tag - finerenone

Explore WCN’26 late-breaking trials with NephJC and Kidney International Reports® 

NephJC has extended the conversation around WCN’26 late-breaking trials with expert commentary on selected studies presented in Yokohama, including the ASSIST trial, 24-month data from APPLAUSE-IGAN, and new analyses from the CONFIDENCE trial.  Read the commentaries  A video interview recorded onsite at WCN’26 in Yokohama features NephJC Founding Editor-in-Chief Swapnil Hiremath and Managing Editor Cristina Popa discussing selected late-breaking...

CONFIDENCE trial: Dual therapy shows promise for CKD and diabetes  

ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes the design and outcomes of the latest “Trial of the month” featured in ISN-ACT GTF.  Trial of the month:  Stronger together: Finerenone & empagliflozin boost kidney outcomes in diabetes  Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes  Agarwal R, et al., N Engl J...